Gentibio raises $157M in series A, targeting type 1 diabetes with its Tregs
Boston-based Gentibio launched in August last year with $20 million seed funding from Orbimed, Novartis Venture Fund and RA Capital. Those … Read more @ www.bioworld.com
Gentibio raises $157M in series A, targeting type 1 diabetes with its Tregs
Boston-based Gentibio launched in August last year with $20 million seed funding from Orbimed, Novartis Venture Fund and RA Capital. Those … Read more @ www.bioworld.com
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
